These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33191181)

  • 1. Influence of everolimus-based treatment on circulating regulatory T cells after liver transplantation: Comparative study with tacrolimus-based therapy.
    Barjon C; Dahlqvist G; Ghazal K; Saliba F; Durand F; Duvoux C; Aoudjehane L; Conti F
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101559. PubMed ID: 33191181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with mTOR inhibitors after liver transplantation enables a sustained increase in regulatory T-cells while preserving their suppressive capacity.
    Ghazal K; Stenard F; Dahlqvist G; Barjon C; Aoudjehane L; Scatton O; Conti F
    Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):237-244. PubMed ID: 29175009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different immunosuppressive combinations on T-cell regulation in renal transplant recipients.
    Fourtounas C; Dousdampanis P; Sakellaraki P; Rodi M; Georgakopoulos T; Vlachojannis JG; Mouzaki A
    Am J Nephrol; 2010; 32(1):1-9. PubMed ID: 20484893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
    Jamali S; Sarafnejad A; Ahmadpoor P; Nafar M; Karimi M; Eteghadi A; Yekaninejad MS; Amirzargar AA
    Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans.
    Lim TY; Perpiñán E; Londoño MC; Miquel R; Ruiz P; Kurt AS; Kodela E; Cross AR; Berlin C; Hester J; Issa F; Douiri A; Volmer FH; Taubert R; Williams E; Demetris AJ; Lesniak A; Bensimon G; Lozano JJ; Martinez-Llordella M; Tree T; Sánchez-Fueyo A
    J Hepatol; 2023 Jan; 78(1):153-164. PubMed ID: 36087863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune and gene expression profiling during tacrolimus to everolimus conversion early after liver transplantation.
    Mathew JM; Kurian S; Cravedi P; Tambur A; Guo K; Zhao L; Levitsky J
    Hum Immunol; 2021 Feb; 82(2):81-88. PubMed ID: 33213941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs.
    Aly MG; Ibrahim EH; Karakizlis H; Weimer R; Opelz G; Morath C; Zeier M; Ekpoom N; Daniel V
    Front Immunol; 2021; 12():716559. PubMed ID: 34335631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice.
    Ma A; Qi S; Wang Z; Massicotte E; Dupuis M; Daloze P; Chen H
    Int Immunopharmacol; 2009 May; 9(5):553-63. PubMed ID: 19539558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The calcineurin inhibitor tacrolimus allows the induction of functional CD4CD25 regulatory T cells by rabbit anti-thymocyte globulins.
    Sewgobind VD; van der Laan LJ; Kho MM; Kraaijeveld R; Korevaar SS; Mol W; Weimar W; Baan CC
    Clin Exp Immunol; 2010 Aug; 161(2):364-77. PubMed ID: 20528886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the impact of conventional immunosuppressant on the establishment of murine transplantation tolerance - an experimental study.
    Katsumata H; Miyairi S; Ikemiyagi M; Hirai T; Fukuda H; Kanzawa T; Ishii R; Saiga K; Ishii Y; Omoto K; Okumi M; Yokoo T; Tanabe K
    Transpl Int; 2019 Apr; 32(4):443-453. PubMed ID: 30561097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of everolimus initiation and early calcineurin inhibitor withdrawal on myocardial FOXP3+ regulatory T cells in heart transplantation.
    Mirza K; Gustafsson F; Gullestad L; Arora S; Andersen C
    Transpl Immunol; 2016 Sep; 38():75-7. PubMed ID: 27260644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Foxp3-expressing regulatory T-cells by donor blood transfusion is required for tolerance to rat liver allografts.
    Abe Y; Urakami H; Ostanin D; Zibari G; Hayashida T; Kitagawa Y; Grisham MB
    PLoS One; 2009 Nov; 4(11):e7840. PubMed ID: 19956764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of immunosuppressive drugs on the development of CD4(+)CD25(high) Foxp3(+) T cells in liver transplant recipients.
    Chu Z; Zhang J; Zhao Y; Ji Q; Zhong J; Zhang C; Zhang B
    Transplant Proc; 2010 Sep; 42(7):2599-601. PubMed ID: 20832552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative impact of CD4+CD25+ regulatory T cells and tacrolimus on inhibition of T-cell proliferation in patients with atopic dermatitis.
    Vukmanovic-Stejic M; McQuaid A; Birch KE; Reed JR; Macgregor C; Rustin MH; Akbar AN
    Br J Dermatol; 2005 Oct; 153(4):750-7. PubMed ID: 16181456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripherally circulating CD4⁺ FOXP3⁺ CXCR3⁺ T regulatory cells correlate with renal allograft function.
    Hoerning A; Köhler S; Jun C; Tebbe B; Fu J; Menke J; Wilde B; Dolff S; Feldkamp T; Briscoe DM; Kribben A; Hoyer PF; Witzke O
    Scand J Immunol; 2012 Sep; 76(3):320-8. PubMed ID: 22670785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
    Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
    Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.
    Dummer CD; Carpio VN; Gonçalves LF; Manfro RC; Veronese FV
    Transpl Immunol; 2012 Jan; 26(1):1-10. PubMed ID: 21939765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoregulatory Effects of Everolimus on In Vitro Alloimmune Responses.
    Levitsky J; Miller J; Huang X; Gallon L; Leventhal JR; Mathew JM
    PLoS One; 2016; 11(6):e0156535. PubMed ID: 27275747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose of tacrolimus favors the induction of functional CD4(+)CD25(+)FoxP3(+) regulatory T cells in solid-organ transplantation.
    Wang Z; Shi B; Jin H; Xiao L; Chen Y; Qian Y
    Int Immunopharmacol; 2009 May; 9(5):564-9. PubMed ID: 19557878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low circulating regulatory T-cell levels after acute rejection in liver transplantation.
    Demirkiran A; Kok A; Kwekkeboom J; Kusters JG; Metselaar HJ; Tilanus HW; van der Laan LJ
    Liver Transpl; 2006 Feb; 12(2):277-84. PubMed ID: 16447185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.